北京先声祥瑞生物制品股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Group A pIus Group C Meningococcal Conjugate Vaccine
- Product Name
- 瑙幔宁
- Approval Number
- 国药准字S20110002
- Approval Date
- Aug 1, 2022
NMPA
Purified Protein Derivative of Tuberculin(TB-PPD)
- Product Name
- 结核菌素纯蛋白衍生物
- Approval Number
- 国药准字S10960017
- Approval Date
- Jun 4, 2021
NMPA
Purified Protein Derivative of Tuberculin(TB-PPD)
- Product Name
- 结核菌素纯蛋白衍生物
- Approval Number
- 国药准字S10960016
- Approval Date
- Jun 4, 2021
NMPA
Purified Protein Derivative of BCG(BCG-PPD)
- Product Name
- 卡介菌纯蛋白衍生物
- Approval Number
- 国药准字S10960020
- Approval Date
- Jun 4, 2021
NMPA
Purified Protein Derivative of Tuberculin(TB-PPD)
- Product Name
- 结核菌素纯蛋白衍生物
- Approval Number
- 国药准字S10960018
- Approval Date
- Oct 30, 2020
NMPA
Purified Protein Derivative of BCG (BCG-PPD)
- Product Name
- 卡介菌纯蛋白衍生物
- Approval Number
- 国药准字S10960019
- Approval Date
- Apr 17, 2020
NMPA
Clinical Trials
No trials found
News
No news found